|
WO2021030701A1
|
|
Improved lipid nanoparticles for delivery of nucleic acids
|
|
WO2020146805A1
|
|
Lipids for lipid nanoparticle delivery of active agents
|
|
WO2020081938A1
|
|
Lipids for lipid nanoparticle delivery of active agents
|
|
CA3113449A1
|
|
Systems and methods for manufacturing lipid nanoparticles and liposomes
|
|
WO2019089828A1
|
|
Lamellar lipid nanoparticles
|
|
US2020172472A1
|
|
Lipids for use in lipid nanoparticle formulations
|
|
US2021122703A1
|
|
Lipids for use in lipid nanoparticle formulations
|
|
US2021122702A1
|
|
Lipids for use in lipid nanoparticle formulations
|
|
WO2019036008A1
|
|
Lipids for use in lipid nanoparticle formulations
|
|
AU2018256877A1
|
|
Novel carbonyl lipids and lipid nanoparticle formulations for delivery of nucleic acids
|
|
WO2018191657A1
|
|
Lipids for delivery of active agents
|
|
WO2018191719A1
|
|
Lipid delivery of therapeutic agents to adipose tissue
|
|
AU2017374042A1
|
|
Delivery of target specific nucleases
|
|
EP3532103A1
|
|
Lipid nanoparticle formulations
|
|
US2019022247A1
|
|
Lipids and lipid nanoparticle formulations for delivery of nucleic acids
|
|
CN108368028A
|
|
Novel lipid and lipid nanoparticle preparation for delivering nucleic acid
|
|
US2016376224A1
|
|
Lipids and lipid nanoparticle formulations for delivery of nucleic acids
|
|
CN106795096A
|
|
Novel lipid and lipid nanoparticle preparation for delivering nucleic acid
|
